Literature DB >> 15668802

Myocardial ultrastructure in cardiac hypertrophy induced by thyroid hormone--an acute study in rats.

Li Wen Hu1, Edson Aparecido Liberti, Maria Luiza Morais Barreto-Chaves.   

Abstract

The early responses of the myocardium ultrastructure under thyroid dysfunction conditions, hemodynamic parameters, cardiac hypertrophy and ultrastructural evaluations were performed in hypothyroid and hyperthyroid rats submitted to different doses [T4-25 and T4-100; 0.025 mg and 0.1 mg kg(-1) body weight (BW).per day, respectively)]. All groups were treated for 7 days. The animals were sacrificed, the hearts were excised and weighed and the left ventricle tissue samples were processed for transmission election microscopy. Systolic blood pressure (SBP) was not altered by administration of T4. An increased heart rate and ratio of heart weight to body weight (HW/BW) were found in the hyperthyroid rats. However, the SBP and HW/BW decreased significantly in hypothyroid rats. No significant ultrastructural alterations were detected when the hypothyroid and T4-25 groups were compared with the control group. Alterations of cardiomyocytes nuclei of these groups were also not detected. Notably, disorganization of intercellular junctions was observed in many cardiomyocytes of T4-100 group. The present results indicate that in the early stages of hyperthyroidism, the cardiac hypertrophy development was mainly due to direct effects of thyroid hormone. Despite cardiac hypertrophy development, there is no ultrastructural evidence of myocardial degeneration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15668802     DOI: 10.1007/s00428-004-1175-1

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  24 in total

1.  Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients.

Authors:  B Biondi; E A Palmieri; S Fazio; C Cosco; M Nocera; L Saccà; S Filetti; G Lombardi; F Perticone
Journal:  J Clin Endocrinol Metab       Date:  2000-12       Impact factor: 5.958

Review 2.  Thyroid hormone-targeting the heart.

Authors:  I Klein; K Ojamaa
Journal:  Endocrinology       Date:  2001-01       Impact factor: 4.736

3.  Morphometric study of myocardial hypertrophy induced by abdominal aortic stenosis.

Authors:  P Anversa; G Olivetti; M Melissari; A V Loud
Journal:  Lab Invest       Date:  1979-03       Impact factor: 5.662

Review 4.  Thyroid hormone regulation of gene expression.

Authors:  G A Brent; D D Moore; P R Larsen
Journal:  Annu Rev Physiol       Date:  1991       Impact factor: 19.318

5.  Ultrastructural analysis of left ventricular hypertrophy in rabbits.

Authors:  M A Goldstein; L A Sordahl; A Schwartz
Journal:  J Mol Cell Cardiol       Date:  1974-06       Impact factor: 5.000

Review 6.  Nongenomic actions of thyroid hormone on the heart.

Authors:  Paul J Davis; Faith B Davis
Journal:  Thyroid       Date:  2002-06       Impact factor: 6.568

7.  Early ultrastructural changes in the myocardium following thyroxine-induced hypertrophy.

Authors:  C Craft-Cormney; J T Hansen
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1980

8.  Reversible hypertension and hypothyroidism.

Authors:  R F Bing; R S Briggs; A C Burden; G I Russell; J D Swales; H Thurston
Journal:  Clin Endocrinol (Oxf)       Date:  1980-10       Impact factor: 3.478

9.  Thyrotoxic myopathy. Pathomorphological observations of human material and experimentally induced thyrotoxicosis in rats.

Authors:  A Korényi-Both; I Korényi-Both; B C Kayes
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

Review 10.  Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions.

Authors:  J H Duncan Bassett; Clare B Harvey; Graham R Williams
Journal:  Mol Cell Endocrinol       Date:  2003-12-31       Impact factor: 4.102

View more
  5 in total

1.  Cardiac ACE2/angiotensin 1-7/Mas receptor axis is activated in thyroid hormone-induced cardiac hypertrophy.

Authors:  Gabriela P Diniz; Nathalia Senger; Marcela S Carneiro-Ramos; Robson A S Santos; Maria Luiza M Barreto-Chaves
Journal:  Ther Adv Cardiovasc Dis       Date:  2015-12-28

2.  Early cardiac hypertrophy induced by thyroxine is accompanied by an increase in VEGF-A expression but not by an increase in capillary density.

Authors:  Luana Anjos-Ramos; Marcela S Carneiro-Ramos; Gabriela P Diniz; Joelcimar Martins-Silva; Maria Luiza Morais Barreto-Chaves
Journal:  Virchows Arch       Date:  2006-01-27       Impact factor: 4.064

3.  Short-term thyroid hormone excess affects the heart but does not affect adrenal activity in rats.

Authors:  Ariani Cavazzani Szkudlarek; Bruno Aldenucci; Nelson Itiro Miyagui; Ilana Kassouf Silva; Rosana Nogueira Moraes; Helton Estrela Ramos; Rosalva Tadeu Hochmuller Fogaça
Journal:  Arq Bras Cardiol       Date:  2014-02-10       Impact factor: 2.000

4.  EFFECT OF ASTRAGALOSIDE ON VITAMIN D-RECEPTOR EXPRESSION AFTER ENDOTHELIN-1-INDUCED CARDIOMYOCYTE INJURY.

Authors:  Chen Yunzhi; Chen Jiaxu; Gao Jie; Chai Yihui; Li Wen; Qin Zhong
Journal:  Afr J Tradit Complement Altern Med       Date:  2017-06-05

5.  Global Disruption of α2A Adrenoceptor Barely Affects Bone Tissue but Minimizes the Detrimental Effects of Thyrotoxicosis on Cortical Bone.

Authors:  Gisele M Martins; Marília B C G Teixeira; Marcos V Silva; Bianca Neofiti-Papi; Manuela Miranda-Rodrigues; Patricia C Brum; Cecilia H A Gouveia
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-28       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.